Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
28,406,191
-
Total 13F shares
-
12,949,979
-
Share change
-
+8,211,135
-
Total reported value
-
$605,805,587
-
Put/Call ratio
-
135%
-
Price per share
-
$46.74
-
Number of holders
-
112
-
Value change
-
+$388,736,954
-
Number of buys
-
90
-
Number of sells
-
25
Institutional Holders of Arcturus Therapeutics Holdings Inc. - COMMON STOCK (ARCT) as of Q2 2020
As of 30 Jun 2020,
Arcturus Therapeutics Holdings Inc. - COMMON STOCK (ARCT) was held by
112 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,949,979 shares.
The largest 10 holders included
ARK Investment Management LLC, BlackRock Inc., VANGUARD GROUP INC, Cormorant Asset Management, LP, CITADEL ADVISORS LLC, FMR LLC, FEDERATED HERMES, INC., DEUTSCHE BANK AG\, PRICE T ROWE ASSOCIATES INC /MD/, and EARNEST PARTNERS LLC.
This page lists
112
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.